Filter by:
Topic
Resource Type
Display Only
Showing 35 Results
Value Assessment’s ‘Leaky Bucket’ Problem
In Health Affairs Forefront, NPC outlines the challenges in assessing the value of new treatments and proposes a framework and recommendations to ensure patient access to new therapies and continued…
Multi-Criteria Decision Analysis: A Way to Put Patient Concerns Front and Center in Value Assessment?
NHC and NPC released a white paper outlining multi-criteria decision analysis (MCDA), an approach to value assessment that may more holistically address patients’ concerns, experiences and treatment…
Sustainable Solutions for Patients’ Sake
Blasine Penkowski, Chair of NPC's Board of Directors, proposes some guiding principles on how we can move toward a post-COVID world and build a more resilient system where patients have the care they…
NPC Statement on Racial, Social Injustices and Health Disparities
The recent deaths of George Floyd, Ahmaud Arbery and Breonna Taylor have put a spotlight on the racial and social injustices that are unfortunately pervasive in the United States. The COVID-19…
New National Alliance Report Encourages Inclusion of Employer-Relevant Elements in Value Assessment
The National Alliance of Healthcare Purchaser Coalitions' report evaluated existing value frameworks and offers insights on the relationship between value assessment tools and the employer…
A Conversation About Cystic Fibrosis, Caregiving and Innovation
Lisa Yourman, the mother of two adult children living with cystic fibrosis and the Coalition Chair for Action CF, discusses how advances in medicine and technology are making a difference for her…
How Do We Place a Value on Indirect Treatment Benefits Like Quality of Life?
A study from NPC and RTI Health Solutions evaluated how institutional barriers prevent the inclusion of broader individual and societal benefits associated with new health care innovations from being…
QALY Remains a Challenge, Societal Perspective Presents an Opportunity With ICER’s 2020 Value Assessment Framework
NPC evaluates the extent to which ICER's 2020-2023 value assessment framework addresses needed changes.
Women Matter in Value Assessments
Sarah Wells Kocsis explains why the Society for Women's Health Research is calling on the Institute for Clinical and Economic Review to ensure its value frameworks and assessments “reflect factors…
NPC Weighs in on CMS Oncology Care First Model
NPC submitted comments regarding the Centers for Medicare and Medicaid Services Center for Medicare and Medicaid Innovation informal request for information on the Oncology Care First Model.
Value Assessments Should Encompass More Than Just Medicines
NPC submitted comments to the Institute for Clinical and Economic Review in response to its request for non-drug assessment topics, noting that value assessments should encompass more than just…
Concerns Raised About ICER’s Adapted Value Assessment Methods for High-Impact ‘Single and Short-term Therapies’
NPC outlines concerns with ICER's final adaptations to its value assessment framework for use when reviewing curative therapies.
NPC and PQA Call for Research Proposals on Barriers to Medication Access
The National Pharmaceutical Council and (NPC) and the Pharmacy Quality Alliance (PQA) announced a new funding opportunity, aimed at supporting research to identify systemic approaches for lowering…
NPC Analysis Compares, Contrasts 7 U.S. Value Assessment Frameworks
The National Pharmaceutical Council (NPC) today released an analysis of seven U.S. value assessment frameworks, comparing and contrasting the strengths and limitations associated with each framework…
Are Value Assessment Frameworks Ready for Prime Time?
An analysis from NPC, published in Value in Health, examined efforts from three organizations actively conducting value assessments.
NPC in AJMC: Why We Need Multiple Measures of Cost-Effectiveness in the US
In an editorial for The American Journal of Managed Care, NPC Chief Science Officer and Executive Vice President Dr. Robert Dubois explores the pitfalls of assigning only one organization the…
Rethinking Our Approach to Value Assessment to Ensure the Patient Voice is Heard
According to a panel at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Summit 2018 and summarized this week in Value in Health, even though value assessment frameworks…
NPC Outlines Ways to Make ICER’s Value Assessment Framework More Patient-Centered
NPC submitted comments to the Institute for Clinical and Economic Review (ICER) on ways to improve its value assessment framework and ensure that patient concerns are better addressed in treatment…
Access to Care: Development of a Medication Access Framework for Quality Measurement
A new framework, developed by the Pharmacy Quality Alliance (PQA) and supported by the National Pharmaceutical Council (NPC), identified seven main areas patients encounter while seeking access to…
Personalized Medicine in a World of Value Frameworks
In a commentary published in the Journal of Clinical Pathways, NPC's Dr. Robert W. Dubois explores how to improve value frameworks’ approach to personalized medicine.